449 related articles for article (PubMed ID: 34447376)
1. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications.
Wang DK; Zuo Q; He QY; Li B
Front Immunol; 2021; 12():705999. PubMed ID: 34447376
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives.
Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K
Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for gastrointestinal malignancies.
Toomey PG; Vohra NA; Ghansah T; Sarnaik AA; Pilon-Thomas SA
Cancer Control; 2013 Jan; 20(1):32-42. PubMed ID: 23302905
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications.
Fang P; Zhou J; Liang Z; Yang Y; Luan S; Xiao X; Li X; Zhang H; Shang Q; Zeng X; Yuan Y
Front Immunol; 2022; 13():975986. PubMed ID: 36119033
[TBL] [Abstract][Full Text] [Related]
6. T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.
Amedei A; Niccolai E; D'Elios MM
Clin Dev Immunol; 2011; 2011():320571. PubMed ID: 22110523
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal cancer stem cells as targets for innovative immunotherapy.
Chivu-Economescu M; Necula LG; Matei L; Dragu DL; Neagu AI; Alexiu I; Bleotu C; Diaconu CC
World J Gastroenterol; 2020 Apr; 26(14):1580-1593. PubMed ID: 32327907
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy.
Elkord E; Hawkins RE; Stern PL
Expert Opin Biol Ther; 2008 Apr; 8(4):385-95. PubMed ID: 18352844
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in Gastrointestinal Malignancies.
Mizrahi J; Pant S
Adv Exp Med Biol; 2020; 1244():93-106. PubMed ID: 32301012
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract][Full Text] [Related]
11. Immunologic therapies for gastrointestinal cancers.
Levy B; Deeken JF; Holt G; Marshall JL
Clin Colorectal Cancer; 2005 May; 5(1):37-49. PubMed ID: 15929805
[TBL] [Abstract][Full Text] [Related]
12. New Approaches for Immune Directed Treatment for Ovarian Cancer.
Hardwick N; Frankel PH; Cristea M
Curr Treat Options Oncol; 2016 Mar; 17(3):14. PubMed ID: 26942589
[TBL] [Abstract][Full Text] [Related]
13. Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer.
Jin X; Liu Z; Yang D; Yin K; Chang X
Front Immunol; 2022; 13():948647. PubMed ID: 35844558
[TBL] [Abstract][Full Text] [Related]
14. Immune Therapy in GI Malignancies: A Review.
Wang J; Reiss KA; Khatri R; Jaffee E; Laheru D
J Clin Oncol; 2015 Jun; 33(16):1745-53. PubMed ID: 25918295
[TBL] [Abstract][Full Text] [Related]
15. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Ă–zdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
16. Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy.
Staudt RE; Carlson RD; Snook AE
Cancer Biol Ther; 2022 Dec; 23(1):127-133. PubMed ID: 35129050
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
Lau HCH; Sung JJ; Yu J
Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for esophageal cancer: a 2019 update.
Schizas D; Charalampakis N; Kole C; Mylonas KS; Katsaros I; Zhao M; Ajani JA; Psyrri A; Karamouzis MV; Liakakos T
Immunotherapy; 2020 Feb; 12(3):203-218. PubMed ID: 32208794
[TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint Inhibitors in the Treatment of Gastrointestinal Malignancies: A Review of Current and Future Therapies.
Hsu A; Mendelson L; Almhanna K
R I Med J (2013); 2020 Apr; 103(3):33-37. PubMed ID: 32236159
[TBL] [Abstract][Full Text] [Related]
20. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]